The most available positron radionuclide labeled radiopharmaceuticals for clinical diagnosis are the compounds labelled with 18F
11C
15O and 13N which have short half-life. This review described the syntheses and clinical use of the short half-life positron radionuclide labelled radiopharmaceuticals